Association of SGLT‐2 Inhibitors With Treatment Satisfaction and Diabetes‐Specific and General Health Status in Adults With Cardiovascular Disease and Type 2 Diabetes

Background It is unknown if initiation of a sodium‐glucose cotransporter‐2 inhibitor (SGLT‐2i) is associated with changes in patient‐reported health status outside of clinical trials. Methods and Results Using a prospective observational study design, adults with type 2 diabetes and cardiovascular d...

Full description

Bibliographic Details
Published in:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Main Authors: Qinglan Ding, Erica S. Spatz, James F. Bena, Shannon L. Morrison, Michelle Levay, Haiqun Lin, Margaret Grey, Nancy E. Edwards, Diana Isaacs, Lucianne West, Pamela Combs, Nancy M. Albert
Format: Article
Language:English
Published: Wiley 2023-09-01
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.122.029058